Pharmaceutical companies have traditionally been the ones to develop drugs. But for rare diseases university researchers may play a role.
Developing drugs is typically the domain of large pharmaceutical companies. But here is an example of drug development for a rare pediatric brain cancer that was done in a university setting.
The Family Medicine Forum, Nov. 9, 2017, the Palais des congrès de Montréal.
This week's annual Family Medicine Forum is an opportunity for your family doctor -- to cave or resist in the face of Big Pharma sponsorship and marketing.
Biohacking for cures: what you need to know.
Research shows that money and meals from the pharmaceutical industry do increase the amount doctors prescribe the drugs being marketed.
Big Pharma in Canada is far behind the curve when it comes to disclosing what payments to health-care professionals are for.
Warren Buffett of Berkshire Hathaway, Jeff Bezos of Amazon and Jamie Dimon of JPMorgan Chase created a health venture in January.
AP File Photos.
Noted physician and author Atul Gawande was named CEO of a new health care venture aimed at cutting costs and improving care. But the most important man to keep an eye on in this effort isn't Gawande. It's the middleman.
As of June 2018, the U.S. is short on 182 drugs and medical supplies, including IV bags.
Sherry Yates Young/shutterstock.com
The US is currently short on 182 drugs and medical supplies. The problem isn't new, but it's frustrating health care workers.
President Donald Trump releases a ‘blueprint’ to reduce prescription drug prices, with Health and Human Services Secretary Alex Azar, in the Rose Garden of the White House in Washington, May 11, 2018.
(AP Photo/Carolyn Kaster)
The logic behind U.S. president Donald Trump's proposal that Canada and other countries have been “free-riding” off high prices in the United States is bizarre at best.
How a technology born from finance – the blockchain – can help the pharmaceutical industry to carry out clinical trials that protect patients.
The Saint Regis Mohawk tribe has struck a multimillion-dollar deal with Allergan. But the deal may do more harm than good.
Michelle Holley holds a photograph of her daughter Jaime Holley, 19, who died of a heroin overdose in November 2016.
Lynne Sladky/AP Photo
Your guide to a public health crisis that's likely to get worse.
Schedule 2 narcotics: Morphine Sulfate, OxyContin and Opana.
Rich Pedroncelli/AP Photo
How can we fight the opioid epidemic? Redesign the drugs, rethink how we assess patients and mandate prescription monitoring.
New Zealand shows up Australia as badly in the field of pharmaceuticals as it does on the rugby field.
Drug prices in Australia are three times higher than in New Zealand. A key reason is the lack of transparency about taxpayer subsidies for Big Pharma and the companies' own finances.
Dozens of studies and numerous reviews have demonstrated the safety of vaccines.
In an era when opinion often trumps evidence in public health issues, it's time to support and invest in evidence-based medicine to protect the public from dangerous, poorly informed beliefs.
Ohio is fighting to hold drug companies accountable for their role in the opioid epidemic.
The state of Ohio filed a lawsuit against opioid manufacturers. Will their legal arguments hold up in court – and what will it mean for other cities and states going after big pharma?
Now you can find out who’s wining and dining our doctors, nurses and pharmacists with publicly available data of drug company funded events.
Drug companies funded more than 116,000 educational events for doctors over four years. Now you can find out exactly which companies footed the bills and how much they paid.
Medical panels are constantly lowering thresholds across many diseases, which results in more and more healthy people being diagnosed as sick.
More of us are labelled as sick with the constantly changing diagnostic cut-offs for diseases. Now an international expert panel has drafted a list of things to consider before setting new thresholds.
Weaker regulatory standards in the US can impact health everywhere.
Intuitively, it might seem desirable to speed up access to medicines. But this means more drugs will be approved that may subsequently prove unsafe or ineffective.
Ababil Wings SS / shutterstock
We have barely begun to tap into the pharmaceutical potential of the most diverse animals of all.
Childhood cancer desperately needs more research.
Children's cancer is a rare disease, which means the market is small and pharmaceutical companies have few incentives to develop drugs for these cancers.
An injectable medication.
The maker of the EpiPen has raised the price of two injectable treatments to about US$600, six times the price nine years ago. Why do drug companies do this? Because they can. The FDA ends up helping.